cagrilintide 2.5 mg + Samaglutide 2.5 mg

A co-formulated treatment combining Cagrilintide (an amylin analog) and Semaglutide (a GLP-1 agonist). The synergetic effect targets multiple metabolic pathways to suppress appetite heavily and maximize body weight reduction.